H.R. 4030

119 HR 4030 IH: Treatment Continuity Act of 2025
 U.S. House of Representatives
 2025-06-17
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 4030  IN THE HOUSE OF REPRESENTATIVES   June 17, 2025   Mr. Dunn of Florida  (for himself,  Mr. Soto , and  Mr. Bean of Florida ) introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes.
1.
Short title
This Act may be cited as the   Treatment Continuity Act of 2025  .
2.
Priority substance use disorder and serious mental illness treatment needs of regional and national significance
(a)
In general
Section 509 of the Public Health Service Act ( 42 U.S.C. 290bb–2 ) is amended—
(1)
in the section heading, by inserting
AND SERIOUS MENTAL ILLNESS   after
SUBSTANCE USE DISORDER  ;
(2)
in subsection (a)—
(A)
in the matter preceding paragraph (1), by inserting  and serious mental illness  after  substance use disorder ; and
(B)
by striking paragraphs (1) through (3) and inserting the following:
(1)
access to long-acting injectable medications that are approved by the Food and Drug Administration for the treatment of individuals with substance use disorders or serious mental illness;
(2)
lab testing and supportive counseling for substance use disorder and serious mental illness; and
(3)
training on the use of long-acting injectable medications for the purposes described in paragraph (1), in combination with associated clinical services such as counseling.
 ;
(3)
in subsection (b)—
(A)
in the subsection heading, by inserting
and Serious Mental Illness   after
Substance Use Disorder  ; and
(B)
in paragraphs (1) and (2), by inserting  and serious mental illness  after  substance use disorder ;
(4)
by striking subsections (d) and (e) and inserting the following:
(d)
Annual report to Congress
Not later than 1 year after the date of enactment of the Treatment Continuity Act of 2025, and annually thereafter during the term of the program under this section, the Secretary shall transmit to Congress a report on the outcomes of such program, including completed or substantial progress toward treatment requirements based on clinician assessment.
 ; and
(5)
by redesignating subsection (f) as subsection (e).
(b)
Applicability
The amendments made by this section shall apply to grants made under section 509 of the Public Health Service Act after the date of the enactment of this Act.